The Directors at Skye Bioscience provide strategic oversight and guidance to the company’s operations, focusing on advancing cannabinoid-derived therapies for glaucoma and other unmet medical needs. They ensure alignment with regulatory standards, drive corporate governance, and foster partnerships to enhance research and development initiatives.